Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.
In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.
Racial disparities in COVID-19 mortality in the U.S. are associated with social factors like income, education, and internet access, according to a Rutgers study published in the Journal of Racial and Ethnic Health Disparities.
The global health consequences and moral implications of wealthy countries hoarding vaccines could be quite serious, said institute director Richard Marlink in a story published by The Daily Targum.
Watch a time-lapse video of Rutgers students assembling COVID-19 testing kits, part of a volunteer effort organized by the Rutgers Global Health Institute Student Council. Plus, find out how you can help.
In a television interview broadcast by NJ Spotlight News, institute director Richard Marlink discusses the COVID-19 vaccine. Topics include how long immunity might last and roadblocks in rolling out a vaccination program.
In an interview about COVID-19 vaccines, institute director Richard Marlink discusses that people may need to get vaccinated annually as well as the importance of a global approach to controlling the pandemic.